Aidapak Recalls Melatonin Tablets Due to Potential Label Mixup
Aidapak Services, LLC is recalling 1 mg Melatonin tablets because they may be mislabeled as other medications. The affected products were distributed in four western states.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a moderate severity score. The hazard is a labeling mixup, which is a minor labeling error that could lead to incorrect medication use, but no specific injuries or illnesses are reported in the source text.
Plain-English summary
Aidapak Services, LLC is recalling 360-count bottles of 1 mg Melatonin tablets (NDC 47469000466) due to a labeling error. The recall is initiated because the Melatonin tablets may be potentially mislabeled as hydrOXYzine PAMOATE, Capsule, 100 mg, or GLUCOSAMINE/CHONDROITIN DS, Tablet, 500 mg/400 mg.
The repacked drugs were distributed in Arizona, California, Oregon, and Washington. The affected Melatonin tablets have specific pedigree codes and expiration dates: Pedigree AD46257_19 with an expiration date of 5/15/2014, and Pedigree AD60240_14 with an expiration date of 5/22/2014.
Consumers should check their medication labels to ensure they are not holding the affected Melatonin products. If the product matches the description and codes provided, consumers should stop using it and contact their pharmacist or the recalling firm for further instructions.
The recalled product
- Product
- MELATONIN Tablet, 1 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 47469000466
- Manufacturer
- Aidapak Services, LLC
- Hazard
- Affected units
- 360
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- MELATONIN
- Tablet
- 1 mg has the following codes Pedigree: AD46257_19
- EXP: 5/15/2014
- Pedigree: AD60240_14
- EXP: 5/22/2014.
Distribution
Part of a larger recall action
This product is one of 273 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 273 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- ModerateHalyard Laparoscopy Comprehensive Pack II Recalled for Latex Content
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateAidapak Recalls Clindamycin Capsules Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Multivitamin Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Pyridoxine HCL Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- SevereAidapak Recalls Digoxin Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Pyridoxine HCL Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- SevereAidapak Recalls Lovastatin Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29